Chromosomes humains de la paire 15 : Questions médicales fréquentes
Nom anglais: Chromosomes, Human, Pair 15
Descriptor UI:D002884
Tree Number:G05.360.162.520.300.370.385
Termes MeSH sélectionnés :
Meta-Analysis as Topic
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes humains de la paire 15 : Questions médicales les plus fréquentes",
"headline": "Chromosomes humains de la paire 15 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chromosomes humains de la paire 15 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-05",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chromosomes humains de la paire 15"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chromosomes humains 13-15",
"url": "https://questionsmedicales.fr/mesh/D002901",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes humains 13-15",
"code": {
"@type": "MedicalCode",
"code": "D002901",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.162.520.300.370"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes humains de la paire 15",
"alternateName": "Chromosomes, Human, Pair 15",
"code": {
"@type": "MedicalCode",
"code": "D002884",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arang Rhie",
"url": "https://questionsmedicales.fr/author/Arang%20Rhie",
"affiliation": {
"@type": "Organization",
"name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA."
}
},
{
"@type": "Person",
"name": "Sergey Koren",
"url": "https://questionsmedicales.fr/author/Sergey%20Koren",
"affiliation": {
"@type": "Organization",
"name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA."
}
},
{
"@type": "Person",
"name": "Erik Garrison",
"url": "https://questionsmedicales.fr/author/Erik%20Garrison",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA."
}
},
{
"@type": "Person",
"name": "Jennifer L Gerton",
"url": "https://questionsmedicales.fr/author/Jennifer%20L%20Gerton",
"affiliation": {
"@type": "Organization",
"name": "Stowers Institute for Medical Research, Kansas City, MO, USA."
}
},
{
"@type": "Person",
"name": "Andrea Guarracino",
"url": "https://questionsmedicales.fr/author/Andrea%20Guarracino",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Uncovering the extent of dementia prevalence in Iran: a comprehensive systematic review and meta-analysis.",
"datePublished": "2024-04-25",
"url": "https://questionsmedicales.fr/article/38664651",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-18415-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Perinatal and neurodevelopmental outcomes of fetal isolated ventriculomegaly: a systematic review and meta-analysis.",
"datePublished": "2024-04-24",
"url": "https://questionsmedicales.fr/article/38715672",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.21037/tp-23-548"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effectiveness of instrument-assisted soft tissue mobilization on range of motion: a meta-analysis.",
"datePublished": "2024-04-23",
"url": "https://questionsmedicales.fr/article/38654270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12891-024-07452-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Imiquimod Is Effective in Reducing Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis.",
"datePublished": "2024-04-22",
"url": "https://questionsmedicales.fr/article/38672691",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cancers16081610"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utilizing Artificial Intelligence Among Patients With Diabetes: A Systematic Review and Meta-Analysis.",
"datePublished": "2024-04-22",
"url": "https://questionsmedicales.fr/article/38779284",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.58713"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Chromosomes",
"item": "https://questionsmedicales.fr/mesh/D002875"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chromosomes de mammifère",
"item": "https://questionsmedicales.fr/mesh/D033481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chromosomes humains",
"item": "https://questionsmedicales.fr/mesh/D002877"
},
{
"@type": "ListItem",
"position": 7,
"name": "Chromosomes humains 13-15",
"item": "https://questionsmedicales.fr/mesh/D002901"
},
{
"@type": "ListItem",
"position": 8,
"name": "Chromosomes humains de la paire 15",
"item": "https://questionsmedicales.fr/mesh/D002884"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chromosomes humains de la paire 15 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chromosomes humains de la paire 15",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chromosomes humains de la paire 15",
"description": "Comment diagnostiquer une anomalie du chromosome 15 ?\nQuels tests génétiques sont utilisés pour le chromosome 15 ?\nQuels signes cliniques indiquent une anomalie sur le chromosome 15 ?\nPeut-on détecter des anomalies chromosomiques in utero ?\nQuel rôle joue le conseil génétique dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Meta-Analysis+as+Topic&page=997#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chromosomes humains de la paire 15",
"description": "Quels symptômes sont associés à la trisomie 15 ?\nComment se manifeste le syndrome de Prader-Willi ?\nQuels troubles sont liés à des anomalies du chromosome 15 ?\nLes anomalies du chromosome 15 affectent-elles le comportement ?\nQuels signes peuvent indiquer un syndrome d'Angelman ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Meta-Analysis+as+Topic&page=997#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chromosomes humains de la paire 15",
"description": "Peut-on prévenir les anomalies chromosomiques ?\nQuel rôle joue le dépistage prénatal ?\nLes antécédents familiaux influencent-ils le risque ?\nComment le mode de vie peut-il affecter le risque ?\nLes vaccinations influencent-elles les anomalies chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Meta-Analysis+as+Topic&page=997#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chromosomes humains de la paire 15",
"description": "Quels traitements sont disponibles pour le syndrome d'Angelman ?\nComment gérer les symptômes de la trisomie 15 ?\nY a-t-il des médicaments pour traiter les troubles liés au chromosome 15 ?\nQuel rôle joue la thérapie comportementale ?\nLes interventions précoces sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Meta-Analysis+as+Topic&page=997#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chromosomes humains de la paire 15",
"description": "Quelles complications peuvent survenir avec le syndrome d'Angelman ?\nLes anomalies du chromosome 15 peuvent-elles affecter la santé physique ?\nY a-t-il des risques de maladies associées ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Meta-Analysis+as+Topic&page=997#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chromosomes humains de la paire 15",
"description": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?\nLe tabagisme influence-t-il le risque d'anomalies ?\nL'exposition à des toxines est-elle un facteur de risque ?\nLes maladies maternelles influencent-elles le risque ?\nLe stress maternel a-t-il un impact sur le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Meta-Analysis+as+Topic&page=997#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie du chromosome 15 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un caryotype ou une analyse génétique peut révéler des anomalies sur le chromosome 15."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés pour le chromosome 15 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'analyse de l'ADN, le séquençage et les tests de microdélétions."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une anomalie sur le chromosome 15 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des retards de développement, des troubles du comportement ou des malformations peuvent indiquer une anomalie."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies chromosomiques in utero ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests comme l'amniocentèse peuvent détecter des anomalies chromosomiques in utero."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le conseil génétique dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le conseil génétique aide à comprendre les risques et les implications des anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la trisomie 15 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des retards de développement, des problèmes d'apprentissage et des malformations."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le syndrome de Prader-Willi ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il se manifeste par une hyperphagie, un retard de développement et des problèmes hormonaux."
}
},
{
"@type": "Question",
"name": "Quels troubles sont liés à des anomalies du chromosome 15 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles comme l'autisme, le syndrome d'Angelman et le syndrome de Prader-Willi sont liés."
}
},
{
"@type": "Question",
"name": "Les anomalies du chromosome 15 affectent-elles le comportement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles du comportement et des difficultés sociales."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer un syndrome d'Angelman ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent des troubles de la marche, des rires inappropriés et des retards de langage."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies chromosomiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies ne peuvent pas être prévenues, mais le conseil génétique peut aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le dépistage prénatal ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage prénatal permet d'identifier les risques d'anomalies chromosomiques chez le fœtus."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'anomalies chromosomiques augmentent le risque pour les descendants."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie peut-il affecter le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire certains risques, mais ne prévient pas toutes les anomalies."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les anomalies chromosomiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne sont pas liées aux anomalies chromosomiques et sont sûres."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le syndrome d'Angelman ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie physique, l'orthophonie et des interventions comportementales."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes de la trisomie 15 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des thérapies éducatives, comportementales et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments pour traiter les troubles liés au chromosome 15 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer les symptômes comme l'anxiété ou l'hyperactivité."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la thérapie comportementale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à améliorer les compétences sociales et à gérer les comportements difficiles."
}
},
{
"@type": "Question",
"name": "Les interventions précoces sont-elles efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent améliorer le développement et la qualité de vie des enfants affectés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le syndrome d'Angelman ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes de sommeil, des troubles de l'alimentation et des crises."
}
},
{
"@type": "Question",
"name": "Les anomalies du chromosome 15 peuvent-elles affecter la santé physique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des problèmes de croissance, d'obésité et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies associées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des risques de maladies comme le diabète et des troubles cardiovasculaires peuvent exister."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en limitant les activités et en nécessitant des soins constants."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup nécessitent un suivi à long terme."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge maternel avancé et des antécédents familiaux d'anomalies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque d'anomalies ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme pendant la grossesse peut augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les maladies maternelles influencent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies maternelles, comme le diabète, peuvent augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Le stress maternel a-t-il un impact sur le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un stress élevé pendant la grossesse peut influencer le développement fœtal et le risque d'anomalies."
}
}
]
}
]
}
Dementia is one of the major causes of disability and dependency among older people worldwide. The formation of an aging population in Iran can be associated with societal problems, including age-rela...
A systematic review and meta-analysis study included articles published in both English and Persian languages and utilized various databases including: Google Scholar, PubMed, Web of Science, Magiran,...
The meta-analysis considered nine relevant studies that were carried out up to 2023 in Iran. The study found that the prevalence of dementia in central and east counties was estimated to be 0.14 (95% ...
This is the first systematic review and meta-analysis of the prevalence of dementia's disease up to 2023 in Iran. The estimated overall prevalence of dementia is lower than the reported prevalence in ...
Isolated fetal ventriculomegaly can have a range of consequences, ranging from mild neurodevelopmental delay to perinatal death; the extent of these consequences often depend on the severity of ventri...
PubMed, Embase, Scopus and the Cochrane Library were searched electronically to identify studies investigating the prognosis of mild and/or severe isolated fetal ventriculomegaly. Articles were includ...
Following the removal of duplicates, the search yielded 2,452 citations, of which 23 studies were included and 8 were eligible for meta-analysis. There were 767 and 347 cases of mild and severe isolat...
The likelihood of adverse neurodevelopmental and perinatal outcomes, including intrauterine and infant mortality, is increased in severe isolated fetal ventriculomegaly compared to mild isolated fetal...
To evaluate the effectiveness of instrument-assisted soft tissue mobilization (IASTM) on range of motion (ROM)....
We performed a literature search of the PubMed, Embase, Web of Science, and Cochrane Library databases from inception to December 23, 2023. Randomized controlled trials that compared treatment groups ...
Nine trials including 450 participants were included in the quantitative analysis. The IASTM was effective in improving ROM in degree in healthy individuals with ROM deficits and patients with musculo...
IASTM can improve ROM in degree in healthy individuals with or without ROM deficits, or in patients with musculoskeletal disorders (with very low to low certainty)....
The PROSPERO registration ID is CRD42023425200....
Topical Imiquimod is an immune response modifier approved for the off-label use of vulvar intraepithelial neoplasia. We conducted this systematic review and meta-analysis to investigate the efficacy a...
The study was prospectively registered (CRD420222870) and involved a comprehensive systematic search of five medical databases on 10 October 2022. We included articles that assessed the use of Imiquim...
Eight articles reported on 398 patients who received Imiquimod out of 672 patients. Among CIN-2-3 patients, we observed a pooled regression rate of 61% (CI: 0.46-0.75;...
Our findings indicate that topical Imiquimod is safe and effective in reducing cervical intraepithelial neoplasia and promoting HPV clearance. However, it was found to be inferior compared to conizati...
Diabetes mellitus, a condition characterized by dysregulation of blood glucose levels, poses significant health challenges globally. This meta-analysis and systematic review aimed to evaluate the effe...
Lifestyle choices, metformin, and dietary supplements may prevent GDM, but the effect of intervention characteristics has not been identified. This review evaluated intervention characteristics to inf...
Ovid, MEDLINE/PubMed, and EMBASE databases were searched. The Template for Intervention Description and Replication (TIDieR) framework was used to examine intervention characteristics (who, what, when...
116 studies involving 40,940 participants are included. Group-based physical activity interventions (RR 0.66; 95% CI 0.46, 0.95) reduce the incidence of GDM compared with individual or mixed (individu...
Dietary, physical activity, diet plus physical activity, metformin, and myoinositol interventions reduce the incidence of GDM compared with control interventions. Group and healthcare facility-based p...
To investigate the relationship between structural empowerment and job satisfaction among nurses....
Job satisfaction is considered to be a global concern. It is also essential to improve the quality of patient care and promote nurse retention. Structural empowerment of nurses can be an important fac...
This meta-analysis was conducted ensuring compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Using seven databases, including PubMed, Science Direct, Sc...
In total, 29 studies involving 30 cohorts (N = 11,078) were identified as eligible for the meta-analysis. A significant positive relationship between nurse structural empowerment and job satisfaction ...
There was a strong positive relationship between structural empowerment and job satisfaction in nurses. Exploring the relationship between structural empowerment and job satisfaction can provide strat...
The results of this study confirmed a strong positive relationship between nurses' job satisfaction and structural empowerment. Implementing interventions that enhance the structural empowerment of nu...
To identify and quantify the factors associated with the reparability of rotator cuff tears (RCTs)....
PubMed, Scopus, and Web of Science databases were searched for clinical studies published in English focusing on RCT reparability by using the keywords "rotator cuff tear" and "reparability". A meta-a...
Eighteen studies (2700 patients) were enrolled, and 26 factors were included in the meta-analysis. The dichotomous variables associated with irreparability were Patte stage 3 (Odds ratio (OR): 8.0, 95...
This study revealed that older age, larger tear size, severe fatty infiltration, muscle atrophy, and advanced superior migration of the humeral head were strongly associated with irreparable RCTs. Con...
Whether mice can be used as a foot-and-mouth disease (FMD) model has been debated for a long time. However, the major histocompatibility complex between pigs and mice is very different. In this study,...
This meta-analysis aimed to examine the safety of masitinib in patients with neurodegenerative diseases....
We considered randomized controlled trials (RCTs) comparing different doses of masitinib versus placebo. We performed our analysis using the R (v.4.3.0) programming language and the incidence of adver...
We included five RCTs, focusing on multiple sclerosis (MS), Alzheimer's disease (AD), and amyotrophic lateral sclerosis. The meta-analysis revealed a significantly higher incidence of adverse events i...
Masitinib use in neurodegenerative diseases presents safety concerns that may impact patients' quality of life and require management. Further research is recommended to determine the optimal dose wit...